I agree that this site is using cookies. You can find further informations here.
X
Hsu, Sigmund
54  results:
Search for persons X
?
1

The Use of Apparent Diffusion Coefficient Values for Differ..:

Khalaj, Kamand ; Jacobs, Michael A. ; Zhu, Jay-Jiguang...
Cancers.  16 (2024)  13 - p. 2440 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Phase 1 trial of TPI 287, a microtubule stabilizing agent, ..:

Goldlust, Samuel A ; Nabors, Louis B ; Hsu, Sigmund...
Neuro-Oncology Advances.  6 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
3

A Phase 3b Study for Management of Ocular Side Effects in P..:

Vize, Colin J. ; Kim, Stella K. ; Matthews, Tim...
Ophthalmic Research.  , 2023
Link: https://doi.org/10.1159/..
 
?
4

BIOM-44. IMPROVED OVERALL SURVIVAL OF RECURRENT GLIOBLASTOM..:

Nahm, Joshua ; Schumann, Eva Highberg ; Vu, Mia...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v14-v14 , 2023
Link: https://doi.org/10.1093/..
 
?
5

TIPS-20 A RANDOMIZED, CONTROLLED TRIAL OF BERUBICIN, A TOPO..:

Silberman, Sandra ; Hsu, Sigmund ; Muzyczenko, Zena.
Neuro-Oncology Advances.  5 (2023)  Supplement_3 - p. iii38-iii39 , 2023
Link: https://doi.org/10.1093/..
 
?
6

CTNI-35. A RANDOMIZED, CONTROLLED TRIAL OF BERUBICIN VS. LO..:

Silberman, Sandra ; Muzyczenko, Zena ; Hsu, Sigmund
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v82-v82 , 2023
Link: https://doi.org/10.1093/..
 
?
7

CNSC-37. THE ASSOCIATION BETWEEN THE NUMBER OF HIGH-DOSE ME..:

Nahm, Joshua ; Sinha, Mousumi ; Schumann, Eva Highberg...
Neuro-Oncology.  25 (2023)  Supplement_5 - p. v31-v31 , 2023
Link: https://doi.org/10.1093/..
 
?
8

Addendum: Newly diagnosed papillary craniopharyngioma with ..:

Rao, Mayank ; Bhattacharjee, Meenakshi ; Shepard, Scott.
Oncotarget.  14 (2023)  1 - p. 438-438 , 2023
Link: https://doi.org/10.18632..
 
?
9

Impacts of genotypic variants on survival following reopera..:

Dono, Antonio ; Zhu, Ping ; Holmes, Emma...
Journal of Neuro-Oncology.  156 (2022)  2 - p. 353-363 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed g..:

Lassman, Andrew B ; Pugh, Stephanie L ; Wang, Tony J C...
Neuro-Oncology.  25 (2022)  2 - p. 339-350 , 2022
Link: https://doi.org/10.1093/..
 
?
11

CTNI-52. A RANDOMIZED CONTROLLED TRIAL OF BERUBICIN, A DOXO..:

Silberman, Sandra ; Hsu, Sigmund ; Picker, Don..
Neuro-Oncology.  24 (2022)  Supplement_7 - p. vii84-vii84 , 2022
Link: https://doi.org/10.1093/..
 
?
12

Genomic alterations predictive of response to radiosurgery ..:

Dono, Antonio ; Amsbaugh, Mark ; Martir, Magda...
Journal of Neuro-Oncology.  152 (2021)  1 - p. 153-162 , 2021
Link: https://doi.org/10.1007/..
 
?
13

RTID-03. DESIGN AND INITIATION OF PIVOTAL STUDIES FOR BERUB..:

Silberman, Sandra ; Hsu, Sigmund ; Muczyczenko, Zena...
Neuro-Oncology.  23 (2021)  Supplement_6 - p. vi193-vi193 , 2021
Link: https://doi.org/10.1093/..
 
?
14

CTNI-51. NEUROCOGNITIVE FUNCTION (NCF) OUTCOMES OF RTOG FOU..:

Wefel, Jeffrey S ; Won, Minhee ; Lassman, Andrew...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii54-ii54 , 2020
Link: https://doi.org/10.1093/..
 
?
15

SURG-23. REOPERATION IN MOLECULAR SUBTYPES OF RECURRENT GLI..:

Dono, Antonio ; Zhu, Ping ; Holmes, Emma...
Neuro-Oncology.  22 (2020)  Supplement_2 - p. ii208-ii208 , 2020
Link: https://doi.org/10.1093/..
 
1-15